Hedge Fund Tips

Unusual Options Activity – Gilead Sciences, Inc. (GILD)

Data Source: barchart

Today some institution/fund purchased 1,102 contracts of June $100 strike calls (or the right to buy 110,200 shares of Gilead Sciences, Inc. (GILD) at $100). The open interest was just 465 prior to this purchase. Continue reading “Unusual Options Activity – Gilead Sciences, Inc. (GILD)”

Insider Buying in BioMarin Pharmaceutical Inc. (BMRN)

On August 31, 2020, David Pyott – Director of BioMarin Pharmaceutical Inc. (BMRN) – purchased 12,800 shares of BMRN at $78.26. His out of pocket cost was $1,001,715.

Where is money flowing today?

Data source: Finviz

Tom Hayes – CNBC Indonesia Appearance – 9/1/2020

CNBC Indonesia – Thomas Hayes – Chairman of Great Hill Capital – September 1, 2020.

Part 1

Part 2

Be in the know. 20 key reads for Wednesday…

Coronavirus live updates: Fauci says vaccine could be available earlier than expected (USA Today)
Natural Gas Posts Biggest Monthly Gain Since 2009 (Barron’s)
Mnuchin Says Economy Is Recovering but ‘More Work’ Is Needed to Alleviate Pain (New York Times)
Buffett Seen Liberating His Successor With Not-So-Buffett Moves (Bloomberg)
An outdoor swimming pool in England is using geothermal energy to keep bathers warm (CNBC)
Mortgage demand from homebuyers is now 28% higher than last year (CNBC)
Barron’s Daily: Moviegoing Is Back—and AMC Stock Is Gaining (Barron’s)
Hedge Funds Ditched Tech, Health Care for Financials, Industrials (Barron’s)
Indian Stocks Look Poised for a Strong Rebound. These 2 Sectors Should Do the Best. (Barron’s)
This stock-market metric has correctly predicted presidential election results since 1984 (MarketWatch)
Tasteful Serenity is the Goal of the New Rolls-Royce Ghost (Barron’s)
Billionaire investor Daniel Loeb reverses losses with bets on Amazon, Disney and Alibaba (fn London)
Bridgewater’s Risk-Parity Shift Jolts a $400 Billion Quant Trade (Bloomberg)
Gilead Sciences (GILD), Jounce Therapeutics (JNCE) Announce Exclusive License Agreement for Novel Immunotherapy Program (Street Insider)
Can Steve Cohen Fix America’s Health Care Problem? (Institutional Investor)
U.S. and Global Factory Output Picks Up, but Jobs Picture Is Mixed (Wall Street Journal)
Germany Expects V-Shaped Economic Rebound From Coronavirus (Wall Street Journal)
Covid-19 Plasma Treatment Could Offer Even More Hope (Wall Street Journal)
Why Factories Are So Strong in a Pandemic (Wall Street Journal)
Real Estate Is Now About Location, Location, Isolation (Wall Street Journal)